Intra-tracheal Instillation of Budesonide to Prevent Chronic Lung Disease

Summary

Preterm infants are randomized to received either Intra-tracheal instillation of budesonide using surfactant as vehicle or a placebo. Intra-tracheal instillation of budesonide using surfactant as vehicle would facilitate its delivery to the periphery of the lung and would inhibit lung inflammation and mitigate acute lung injury.

Timeline

Start

2019-12-02

Primary completion

2023-02

Completion

2024-12

Drugs

Indications